Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/23721
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Anti-Arrhythmia Agents/therapeutic use,Antioxidants/pharmacology/*therapeutic use,Diabetes Complications/drug therapy,Diabetes Mellitus/*drug therapy,Fatty Acids/metabolism,Humans,Myocardial Ischemia/complications/*drug therapy,Oxidation-Reduction/drug effects,Oxidative Stress/drug effects,Trimetazidine/pharmacology/*therapeutic use,Vasodilator Agents/therapeutic use
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/23721
ISSN: 1097-6744
Link: http://www.ncbi.nlm.nih.gov/pubmed/15632868
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Korantzopoulos-2004-the potential benefits.pdf42.37 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons